DIA 2019 - There's nothing quite like Encapsia
Jon Carter, Product Manager 01 Aug 2019
What a week in San Diego at DIA 2019! After arriving home late (or early Friday morning) and exhausted from the long journey, I still have an energy coursing through my veins fuelled by the week we left behind. As I reflect what the week meant for us, I feel an excitement about the future of both Encapsia and our industry.
Having observed the conference themes and the offerings from other vendors, I can’t help but feel there is nothing quite like Encapsia. It is not only built for today’s trials, but also for tomorrow’s. One of the themes of the week was the exciting area of artificial intelligence. Encapsia leads the market with analytics capabilities that are already proven to support AI, by analyzing and populating data from CT scans directly into the CRF.
Themes from DIA in previous years, in my opinion, have never fully reached fruition. Have we completely implemented risk based monitoring? There has been some great work in the area, but EDC systems are typically not flexible enough to dynamically adjust SDV down to the datapoint level. Encapsia has no hard-wired SDV mode, but instead has fully configurable review modes that allow you to dynamically set and adjust what requires SDV or any other type of review!
Overall, I am hugely encouraged by what we have seen at DIA 2019. Firstly, the industry is heading in the right direction, and secondly, Encapsia is made for that direction. There really isn’t anything quite like Encapsia for the future of clinical trials.